glp 1 receptor agonists incretin mimetics GLP-1 or DPP-4 inhibitors: How to guide the clinician? GLP1 Receptor Agonists—Effects beyond Obesity

The effects of bariatric surgery on bone and nephrolithiasis

Unlike opioid-based treatments, they do not carry risks of dependency

Footnotes Declaration of Interests JEC and DAD receive funding to carry out basic research from Eli Lilly, Novo Nordisk, and Merck MSD

Lower interest rates have often supported stronger real estate returns and improved valuations

DPP-4 inhibitors can be used as monotherapy when metformin is contraindicated or not tolerated

However, challenges include higher costs and limited long-term safety data, necessitating further studies to confirm its cardiovascular benefits in non-diabetic populations and cerebrovascular conditions, such as vascular dementia [15]